Corpus Intelligence IC Memo — ST. MARY MEDICAL CENTER 2026-04-26 09:38 UTC
IC Memo — ST. MARY MEDICAL CENTER
Investment Committee Memorandum | IL | 83 beds | Grade C | EBITDA uplift $8.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ST. MARY MEDICAL CENTER

CCN 140064 | KNOX, IL | 83 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ST. MARY MEDICAL CENTER is a 83-bed suburban community hospital in KNOX, IL with $116.4M in net patient revenue and a 15.0% operating margin. The hospital serves a payer mix of 36.2% Medicare, 4.7% Medicaid, and 59.1% commercial.

Thesis: Turnaround. Our ML models identify $8.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 15.0% to 22.4% (+736bps).

Net Revenue HCRIS$116.4M
Current EBITDA COMPUTED$17.5M
Operating Margin COMPUTED15.0%
Occupancy HCRIS56.1%
Revenue / Bed COMPUTED$1.4M
Net-to-Gross HCRIS22.7%
Distress Probability ML46.1%

2. Market Context & Competitive Position

208
IL Hospitals
-5.3%
State Median Margin
72
Comparable Hospitals

IL has 208 Medicare-certified hospitals with a median operating margin of -5.3%. The target's margin of 15.0% places it above the state median. Among 72 size-comparable peers (42-166 beds), the median margin is -9.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (42-166), prioritizing same-state peers. 72 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ST. MARY MEDICAL CENTER (Target)IL83$116.4M15.0%
MIDWESTERN REGIONAL MEDICAL CEIL73$1.38B80.5%
NORTHWESTERN LAKE FOREST HOSPIIL124$494.3M-13.8%
SARAH BUSH LINCOLN HEALTH CENTIL100$448.6M-18.1%
DELNOR-COMMUNITY HOSPITALIL149$441.4M6.4%
KISHWAUKEE COMMUNITY HOSPITALIL98$355.3M25.5%
ST. ELIZABETH HOSPITALIL144$296.2M-3.2%
FRANCISCAN ST. JAMES HEALTHIL154$252.2M-32.1%
CGH MEDICAL CENTERIL95$247.1M-7.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.4M+210bp18mo
Cost to Collect4.5%2.5%$2.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.4M+122bp9mo
Clean Claim Rate88.0%96.0%$74K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.4M
Cost to Collect
$2.3M
Denial Rate Reduction
$2.3M
A/R Days Reduction
$1.4M
Clean Claim Rate
$74K
Total EBITDA Uplift$8.6M
Current EBITDA$17.5M
+ RCM Uplift+$8.6M
Pro Forma EBITDA$26.0M
Current Margin15.0%
Pro Forma Margin22.4%
WC Released (1x)$4.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$26.9M$200.9M7.48x49.5%
Base (11x exit)10.0x11.0x$26.9M$229.7M8.55x53.6%
Bull Case9.0x11.0x$24.2M$266.7M11.03x61.6%
Bull (12x exit)9.0x12.0x$24.2M$298.1M12.33x65.3%
Bear Case11.0x10.0x$29.6M$149.3M5.05x38.3%
Bear (11x exit)11.0x11.0x$29.6M$173.9M5.88x42.5%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 72 hospitals with 42-166 beds
  • Same-state prioritization (n=73)
  • Comp margins: P25=-22.6% / P50=-9.1% / P75=4.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.